Cite
HARVARD Citation
Mycock, K. et al. (2022). Real-world treatment patterns and clinical outcomes in patients receiving palbociclib combinations for HR+/HER2– advanced/metastatic breast cancer in Japan: Results from the IRIS study. Cancer treatment and research communications. p. . [Online].